glp-1 constipation diarrhea side effects Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Managing GLP-1/GIP side effects with

Rooted in Nature Backed by Science

GLP-1 weight-loss drugs are taking over the food system, and fast-food chains and supermarkets are the latest to embrace this new order.

Loss of muscle mass and strength not only impairs mobility and quality of life, but also worsens insulin resistance, accelerates cardiometabolic decline and increases mortality risk

The global glucagon-like peptide-1 receptor agonist (GLP-1) market has experienced significant growth and is projected to expand further

Interestingly, this raises important points in regard to the need to hold GLP-1 RAs prior to concurrent EGD and colonoscopy procedures and the number of days needed to hold these agents, if necessary

I designed this schematic on BioRender to visualize what I think is happening to my patients